Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Aortic Valve Diseases RISk facTOr assessmenT and Prognosis modeL Construction

Key facts

Where
Guangzhou, Jieyang, Shantou, Shenzhen, Zhanjiang, and Zhongshan, ChinaSee the 7 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 100 years old?

Source: NCT06069232, who can take part

Where in China

  • First Affiliated Hospital, Sun Yat-Sen UniversityGuangzhou, ChinaContact: xiaodong zhuang, PhDTaking people
  • Third Affiliated Hospital, Sun Yat-Sun UniversityGuangzhou, ChinaContact: zhuoshan Huang, PhDTaking people
  • Jieyang People's HospitalJieyang, ChinaContact: Mingwei Xu, PhDTaking people
  • Second Affiliated Hospital of Shantou University Medical CollegeShantou, ChinaContact: Jilin Li, PhDTaking people
  • Eighth Affiliated Hospital, Sun Yat-sen UniversityShenzhen, ChinaContact: jianwen liang, PhDTaking people
  • Affiliated Hospital of Guangdong Medical UniversityZhanjiang, ChinaContact: Jianying Chen, PhDTaking people
  • Zhongshan People's HospitalZhongshan, ChinaContact: li Feng, PhDTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Sun Yat-sen University
Trial code
NCT06069232
Record updated
12 October 2023
Original description
This study is a multicenter cohort study including patients diagnosed with aortic valve disease during hospitalization, including aortic insufficiency and aortic valve stenosis. The primary outcome of the study was all-cause death, and the secondary outcome was cardiovascular events. Through follow-up observation, the prognostic risk factors of patients with aortic disease were evaluated, and a prognostic model was constructed to guide clinical decision-making.Read full original descriptionShow less

Aortic Valve Diseases RISk facTOr assessmenT and Prognosis modeL Construction (ARISTOTLE)

This study is a multicenter cohort study including patients diagnosed with aortic valve disease during hospitalization, including aortic insufficiency and aortic valve stenosis. The primary outcome of the study was all-cause death, and the secondary outcome was cardiovascular events. Through follow-up observation, the prognostic risk factors of patients with aortic disease were evaluated, and a prognostic model was constructed to guide clinical decision-making.

Inclusion: age ≥ 18; diagnosed as aortic valve disease.

Exclusion: aortic valve replacement at baseline.

ClinicalTrials.gov NCT06069232